UNIQUE FUND-OF-FUNDS APPROACH
With insight in the biotech, pharma and tech sector we access VC funds across the Americas and Europe to significantly diversify investments. This allows mitigation of risk, while gaining access to early-stage investments in the pre-seed to series A-D with significant upside